谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Randomized, Open-Label Phase Ii Study of Efatutazone in Combination with Folfiri As Second-Line Therapy for Metastatic Colorectal Cancer (Mcrc).

John Marshall,Dale Edward Shuster,Terri Robin Goldberg,Catherine Copigneaux,Shuquan Chen,Hamim Zahir,Dipen Dutta,Mansoor N. Saleh,Michael J. Pishvaian, Mirta Susana Varela, Felipe Palazzo,Nicolas Lazaretti,Cassia Costa,Eugenia Loredo,Jorge Leon,Reinhard W. Von Roemeling

JOURNAL OF CLINICAL ONCOLOGY（2014）

引用 2|浏览32
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要